Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 4 5 6 7 8 9 Last 

Alabama

UPDATED

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Arizona

UPDATED

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

Phoenix Arizona 85054

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Arkansas

UPDATED

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

UPDATED

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

UPDATED

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

San Carlos California 94070

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Torrance California 90503

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92037-0845

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

La Jolla California 92093

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Oceanside California 92056

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Palo Alto California 94305

A Phase 2 clinical study for patients with Colitis, Ulcerative

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating fecal calprotectin level for the treatment of Inflammatory Bowel Disease or Irritable Bowel Syndrome (IBS)

San Diego California 92101

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92123

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92101

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92101

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Colorado

UPDATED

Denver Colorado 80045

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Littleton Colorado 80120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Connecticut

UPDATED

Bristol Connecticut 06010

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Danbury Connecticut 06810

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Bristol Connecticut 06010

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Guilford Connecticut 06437

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

View More ▼

Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Hamden Connecticut 06518

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

New Haven Connecticut 06510

A Phase 2 clinical study for patients with Colitis, Ulcerative

First 1 2 3 4 5 6 7 8 9 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.